Desenfants A, Huguon E, Polfrit Y, Crouzat M, Rouleau V, Chassot V, Besson-Leaud L, Missotte I
Service de pédiatrie, hôpital Magenta, centre hospitalier territorial de Nouvelle-Calédonie, BP J5, 98849 Nouméa cedex, France.
Arch Pediatr. 2012 Nov;19(11):1182-6. doi: 10.1016/j.arcped.2012.08.021. Epub 2012 Oct 1.
In developed countries, Hansen disease, or leprosy, is a rare and little-known disease. Over the last few years, its prevalence in New Caledonia has remained stable (0.35 per 10,000 inhabitants). We report the case of an 11-year-old child who presented lepromatous leprosy complicated by a type 2 reaction. Despite appropriate treatment, the course was unusual with fever lasting a few weeks associated with asthenia, weight loss, and biological perturbations such as inflammatory syndrome, anemia, and hyperferritinemia. After a brief review of Hansen disease and its complications, we discuss the different hypotheses that can explain the clinical and biological progression of our patient (hemolytic anemia secondary to dapsone, type 2 reaction, and aspects of hemophagocytic syndrome) and describe therapeutic management, which led to a good outcome.
在发达国家,汉森病即麻风病,是一种罕见且鲜为人知的疾病。在过去几年中,其在新喀里多尼亚的患病率一直保持稳定(每10000名居民中有0.35例)。我们报告了一例11岁儿童的病例,该患儿患有瘤型麻风病并伴有2型反应。尽管进行了适当治疗,但病程异常,发热持续数周,伴有乏力、体重减轻以及炎症综合征、贫血和高铁蛋白血症等生物学紊乱。在简要回顾汉森病及其并发症后,我们讨论了可以解释该患者临床和生物学进展的不同假说(氨苯砜继发的溶血性贫血、2型反应以及噬血细胞综合征的相关方面),并描述了治疗管理情况,最终取得了良好的治疗效果。